Beta Bionics Announces Participation at Upcoming Investor Conferences
Beta Bionics (Nasdaq: BBNX), a leader in advanced diabetes management solutions, has announced its participation in three major healthcare investor conferences in September 2025. The company will present at the Wells Fargo Healthcare Conference (September 4), Morgan Stanley Global Healthcare Conference (September 8), and Baird Global Healthcare Conference (September 10).
Live webcasts will be available for the Wells Fargo and Morgan Stanley presentations through the company's investor relations website, where recordings will also be archived for future viewing.
Beta Bionics (Nasdaq: BBNX), azienda di punta nelle soluzioni avanzate per la gestione del diabete, ha annunciato la sua partecipazione a tre importanti conferenze per investitori del settore sanitario nel settembre 2025. La società interverrà al Wells Fargo Healthcare Conference (4 settembre), al Morgan Stanley Global Healthcare Conference (8 settembre) e al Baird Global Healthcare Conference (10 settembre).
I webcast in diretta saranno disponibili per le presentazioni di Wells Fargo e Morgan Stanley sul sito web per gli investitori dell’azienda; le registrazioni saranno inoltre archiviate per la visione successiva.
Beta Bionics (Nasdaq: BBNX), líder en soluciones avanzadas para el manejo de la diabetes, ha anunciado su participación en tres importantes conferencias de inversores del sector sanitario en septiembre de 2025. La compañía presentará en el Wells Fargo Healthcare Conference (4 de septiembre), en el Morgan Stanley Global Healthcare Conference (8 de septiembre) y en el Baird Global Healthcare Conference (10 de septiembre).
Habrá retransmisiones en directo para las presentaciones de Wells Fargo y Morgan Stanley en la web de relaciones con inversores de la compañía, donde también se archivarán las grabaciones para su visionado posterior.
Beta Bionics (나스닥: BBNX)는 첨단 당뇨병 관리 솔루션 분야의 선도 기업으로서 2025년 9월 주요 의료 투자자 콘퍼런스 세 곳에 참여한다고 발표했습니다. 회사는 Wells Fargo Healthcare Conference(9월 4일), Morgan Stanley Global Healthcare Conference(9월 8일), Baird Global Healthcare Conference(9월 10일)에서 발표할 예정입니다.
Wells Fargo와 Morgan Stanley 발표는 회사의 투자자 관계 웹사이트를 통해 생중계되며, 녹화본도 이후 시청을 위해 보관됩니다.
Beta Bionics (Nasdaq: BBNX), acteur majeur des solutions avancées de gestion du diabète, a annoncé sa participation à trois grandes conférences pour investisseurs du secteur de la santé en septembre 2025. La société interviendra lors de la Wells Fargo Healthcare Conference (4 septembre), de la Morgan Stanley Global Healthcare Conference (8 septembre) et de la Baird Global Healthcare Conference (10 septembre).
Des webcasts en direct seront proposés pour les présentations de Wells Fargo et de Morgan Stanley sur le site relations investisseurs de la société, où les enregistrements seront également archivés pour consultation ultérieure.
Beta Bionics (Nasdaq: BBNX), ein führendes Unternehmen im Bereich fortschrittlicher Lösungen zur Diabetesversorgung, hat seine Teilnahme an drei wichtigen Healthcare-Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird auf der Wells Fargo Healthcare Conference (4. September), der Morgan Stanley Global Healthcare Conference (8. September) und der Baird Global Healthcare Conference (10. September) präsentieren.
Live-Webcasts der Präsentationen bei Wells Fargo und Morgan Stanley werden über die Investor-Relations-Website des Unternehmens verfügbar sein; Aufzeichnungen werden ebenfalls zur späteren Ansicht archiviert.
- None.
- None.
IRVINE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at three upcoming investor conferences (all Eastern Time):
- Wells Fargo 20th Annual Healthcare Conference on Thursday, September 4, 2025 at 3:45pm
- Morgan Stanley 23rd Annual Global Healthcare Conference on Monday, September 8, 2025 at 1:50pm
- Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025 at 9:40am
The presentations at the Wells Fargo and Morgan Stanley conferences will be webcast live. The link to the webcasts will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay following the events.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.
Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com
Media and Public Relations:
Karen Hynes
Vice President of Marketing
media@betabionics.com
Source: Beta Bionics, Inc.
FAQ
When is Beta Bionics (BBNX) presenting at the Wells Fargo Healthcare Conference 2025?
How can investors watch Beta Bionics' (BBNX) conference presentations?
What upcoming investor conferences will Beta Bionics (BBNX) attend in September 2025?
What time is Beta Bionics' (BBNX) presentation at the Morgan Stanley Healthcare Conference?
